Back to School: How biopharma can reboot drug development. Access exclusive analysis here
British Biotech plc (BBIOY), Oxford, U.K. Product: Batimastat matrix metalloproteinase inhibitor Indication: Malignant
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury